Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Hypertension

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.hjh.0000388490.28213.dePMID 20823712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melatonin interactions with blood pressure and vascular function during l‐NAME‐induced hypertension

  2010cited by this paper
• Melatonin: An Established Antioxidant Worthy of Use in Clinical Trials

  2009cited by this paper
• The circadian melatonin rhythm and its modulation: possible impact on hypertension

  2009cited by this paper
• Recent trends in hypertension treatment: perspectives from animal studies

  2009cited by this paper
• Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats

  2009cited by this paper
• Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats

  2009cited by this paper
• Defining chronodisruption

  2009cited by this paper
• Clinical aspects of melatonin.

  2008cited by this paper
• Regression of L-NAME–Induced Hypertension: The Role of Nitric Oxide and Endothelium-Derived Constricting Factor

  2008cited by this paper
• Endothelium‐dependent contractions: when a good guy turns bad!

  2008cited by this paper
• Chronotherapy beyond blood pressure reduction?

  2008cited by this paper
• Blood pressure modulation and cardiovascular protection by melatonin: potential mechanisms behind.

  2007cited by this paper
• LA419, a Novel Nitric Oxide Donor, Prevents Pathological Cardiac Remodeling in Pressure-Overloaded Rats Via Endothelial Nitric Oxide Synthase Pathway Regulation

  2007cited by this paper
• Melatonin as a potential antihypertensive treatment

  2007cited by this paper
• LA419, a novel nitric oxide donor, prevents cardiac remodeling via the endothelial nitric oxide synthase pathway: NO donors as a means of antiremodeling.

  2007cited by this paper
• Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin

  2006cited by this paper
• Effect of simvastatin on remodeling of the left ventricle and aorta in L-NAME-induced hypertension.

  2004cited by this paper
• Role of Nitric Oxide in Central Sympathetic Outflow

  2001cited by this paper
• Chronic inhibition of NO synthesis per se promotes structural intimal remodeling of the rat aorta

  2001cited by this paper
• Regulation of angiotensin II receptor expression by nitric oxide in rat adrenal gland.

  1998cited by this paper
• Endothelial dysfunction in cardiovascular disease: risk factor, risk marker, or surrogate end point?

  1998cited by this paper
• Aspirin improves endothelial dysfunction in atherosclerosis.

  1998cited by this paper
• Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.

  1997cited by this paper
• Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.

  1997cited by this paper
• Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.

  1996cited by this paper
• Endothelial dysfunction in atherosclerosis.

  1996cited by this paper
• Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.

  1992cited by this paper
• Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

  1990cited by this paper
• Potentiation of lipid peroxides by ischemia in rat brain

  1982cited by this paper
• Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

  1977cited by this paper

• Mitochondrial Melatonin: Beneficial Effects in Protecting against Heart Failure

  2024cites this paper
• Altered Balance between Vasoconstrictor and Vasodilator Systems in Experimental Hypertension.

  2024cites this paper
• The Impact of Melatonin and its Agonist on Endothelin-1 Reactivity in Isolated Aorta in Continuous Light and Pinealectomized Rats

  2023cites this paper
• Melatonin as a therapeutic agent for alleviating endothelial dysfunction in cardiovascular diseases: Emphasis on oxidative stress.

  2023cites this paper
• Evidence for the Benefits of Melatonin in Cardiovascular Disease

  2022cites this paper
• Melatonin Attenuates RVLM Neuro-inflammation and Sympathetic Activation in Stress-induced Hypertension Rats

  2020cites this paper
• Effects of melatonin on cardiovascular risk factors and metabolic syndrome: a comprehensive review

  2020cites this paper
• Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension

  2018cites this paper
• Effects of melatonin on mechanisms involved in hypertension using human umbilical vein endothelial cells

  2017influential citation
• Impact of melatonin on central blood pressure regulation

  2017cites this paper
• Effect of melatonin on blood pressure and nitric oxide generation in rats with metabolic syndrome.

  2016cites this paper
• Melatonin and renal protection: novel perspectives from animal experiments and human studies (review).

  2014cites this paper
• Endothelium and Its Alterations in Cardiovascular Diseases: Life Style Intervention

  2014cites this paper
• Melatonin reduces cardiac remodeling and improves survival in rats with isoproterenol‐induced heart failure

  2014cites this paper
• Peripheral and Central Effects of Melatonin on Blood Pressure Regulation

  2014cites this paper
• Doxorubicin-induced behavioral disturbances in rats: protective effect of melatonin and captopril.

  2014cites this paper
• Melatonin as a Therapeutic Agent for Sepsis

  2014cites this paper
• Vascular endothelial cells and dysfunctions: role of melatonin.

  2013influential citation
• Effect of captopril and melatonin on fibrotic rebuilding of the aorta in 24 hour light-induced hypertension.

  2013cites this paper
• Cardiovascular effects of melatonin receptor agonists

  2012cites this paper
• The Presence and Localization of Melatonin Receptors in the Rat Aorta

  2011cites this paper
• Remodelling of the heart and vessels in experimental hypertension: advances in protection

  2010cites this paper